Get help now — free helplines

You can call any of these for free. You do not need a diagnosis, an appointment, or a crisis to call — questions and plain exhaustion are reasons enough.

  • Alzheimer's Association 24/7 Helpline 800-272-3900 24 hours a day, 365 days a year Free, confidential support and information for people with dementia, caregivers, families and the public. Master's-level clinicians. Also Spanish.
  • 988 Suicide & Crisis Lifeline 988 24/7 Call or text 988, or chat at 988lifeline.org. For anyone in emotional distress or a mental-health crisis, including caregivers.
  • Alzheimer's Foundation of America (AFA) Helpline 866-232-8484 9:00 am - 9:00 pm ET, seven days a week Licensed social workers providing support, info and referrals. Also text message and web chat. Text: 646-586-5283

In a medical emergency, call 911. More numbers, and what each line does, on the help page.

Newest in this topic

  1. Pathway-specific polygenic risk scores reveal underlying mechanisms of cerebral small vessel disease 2026-09-14
  2. Cerebral Small Vessel Disease and Risk of Cardiovascular Events and All-Cause Mortality: The Framingham Heart Study 2026-09-07
  3. Regional Distribution of Mineralized Blood Vessels in Alzheimer Disease and Clinicopathological Associations: A Multicenter Autopsy Study 2026-09-01

Studies

903 studies carry this tag.

Date range

1975 to 2026

Top journals

  • Neurology 93
  • Stroke 61
  • Alzheimer s & Dementia 31
  • Brain : a journal of neurology 20
  • Annals of neurology 19

342 journals in all.

Newest first, then by address. Each study has a usefulness score out of 100 (rubric version 4.0); tap a score to see what makes it up. Tags were assigned automatically from each study's title and summary. The same studies as a filter in the library.

  1. Pathway-specific polygenic risk scores reveal underlying mechanisms of cerebral small vessel disease

    ⚠ Preprint — not yet peer-reviewed alzhub usefulness score 16 out of 100. medRxiv (preprint) 2026-09-14 Genetics

    White matter hyperintensities (WMH), a key MRI-marker of cerebral small vessel disease (cSVD), are common in older adults and associated with an increased risk of stroke and dementia.

  2. Cerebral Small Vessel Disease and Risk of Cardiovascular Events and All-Cause Mortality: The Framingham Heart Study

    ⚠ Preprint — not yet peer-reviewed alzhub usefulness score 16 out of 100. medRxiv (preprint) 2026-09-07 Prevention and risk

    O_FIG O_LINKSMALLFIG WIDTH=200 HEIGHT=113 SRC="FIGDIR/small/26361997v1_ufig1.gif" ALT="Figure 1"> View larger version (32K): org.highwire.dtl.DTLVardef@1dac0d9org.highwire.dtl.DTLVardef@aaf8f2org.highwire.dtl.DTLVardef@be10a1org.highwire.dtl.DTLVardef@35c7be_HPS_FORMAT_FIGEXP M_FIG C_FIG BACKGROUNDThe effect of neurovascular health on cardiovascular outcomes is not well-known.

  3. Regional Distribution of Mineralized Blood Vessels in Alzheimer Disease and Clinicopathological Associations: A Multicenter Autopsy Study

    ✓ Peer-reviewed alzhub usefulness score 37 out of 100. Neurobiology of Aging 2026-09-01 Genetics

    Mineralized blood vessels (MBV) are a form of vascular pathology associated with cerebrovascular aging and neurodegeneration; however, their regional distribution and clinicopathological correlates in Alzheimer disease (AD) remain poorly characterized.

  4. Region-specific cerebral blood flow differentiates cognitively impaired and unimpaired individuals with core Alzheimer's disease pathology

    ⚠ Preprint — not yet peer-reviewed alzhub usefulness score 16 out of 100. medRxiv (preprint) 2026-08-25 Genetics

    BackgroundUp to 30% of individuals harboring core Alzheimers disease (AD) neuropathology--amyloid-{beta} (A{beta};A) and tau (T)--remain cognitively unimpaired.

  5. Asymptomatic carotid artery stenosis, cognitive decline and dementia: a prospective population-based cohort study

    ⚠ Preprint — not yet peer-reviewed alzhub usefulness score 16 out of 100. medRxiv (preprint) 2026-08-21 Prevention and risk

    BackgroundAsymptomatic carotid artery stenosis (ACAS) increases the risk of stroke, and is associated with cognitive decline.

  6. Impaired cerebrovascular-cerebrospinal fluid coupling is associated with non-motor features of Lewy body disease

    ⚠ Preprint — not yet peer-reviewed alzhub usefulness score 16 out of 100. medRxiv (preprint) 2026-08-19 Brain scans and imaging

    Parkinsons disease and dementia with Lewy bodies patients both demonstrated weaker global BOLD-CSF coupling compared to controls, with no detectable difference between patient groups.

  7. Diffusion kurtosis imaging (gen)omics unravels mechanisms of cerebral small vessel disease

    ⚠ Preprint — not yet peer-reviewed alzhub usefulness score 16 out of 100. medRxiv (preprint) 2026-08-14 Biomarkers

    Cerebral small vessel disease (cSVD) is a leading cause of stroke and dementia.

  8. Clinical and neuroimaging correlates of motoric cognitive risk syndrome in cerebral small vessel disease: a cross-sectional study

    ✓ Peer-reviewed alzhub usefulness score 48 out of 100. Frontiers in Aging Neuroscience 2026-06-11 Vascular contributions

    Among 225 patients (mean age 65.4 years, 54.2% male), MCR prevalence was 16.4%.

  9. The role of inflammation in cerebral small vessel disease and vascular cognitive impairment, and therapeutic implications

    ✓ Peer-reviewed alzhub usefulness score 51 out of 100. International Journal of Stroke 2026-06-08 Vascular contributions

    Considerable data support the presence of both systemic and CNS inflammation in SVD and VCID.

  10. Convergence of neuroinflammation across major neurotropic viral exposomes in AD and ADRD

    ✓ Peer-reviewed alzhub usefulness score 39 out of 100. Journal of Neuroinflammation 2026-05-29 Inflammation and the immune system

    Across diverse viral infections, strong convergence was observed in innate immune activation pathways, including microglial priming and NLRP3 inflammasome signaling, accompanied by chronic production of proinflammatory cytokines (IL-1β, TNF-α, IFN-γ).

  11. In part 1 of the study, the patients with CSVD showed significant differences in Montreal Cognitive Assessment (MoCA), Auditory Verbal Learning Test (AVLT)-study, AVLT-immediate, AVLT-delay, AVLT-recognition, Trail Making Test (TMT)-A, TMT-B, and Verbal Fluency Test -fruits/vegetables compared with HCs.

  12. Fluid Biomarkers of Cognitive Impairments Following Traumatic Brain Injury: A Systematic Review and Meta Analysis

    ✓ Peer-reviewed alzhub usefulness score 53 out of 100. International journal of molecular sciences 2026-05-11 Disease mechanisms

    Traumatic brain injury (TBI), a major cause of persistent cognitive impairment (CI), increases the long-term risk of developing dementia, including Alzheimer's disease (AD).

  13. Demyelination in Vascular Dementia: Focus on Oligodendrocytes, Microglia, and Their Interaction

    ✓ Peer-reviewed alzhub usefulness score 30 out of 100. Current Neuropharmacology 2026-05-05 Inflammation and the immune system

    Vascular dementia (VaD), a primary cognitive disorder caused by cerebrovascular pathology, features significant white matter damage from chronic cerebral hypoperfusion strongly correlated with cognitive decline.

  14. Astrocytes in Brain Aging and Neurodegeneration: Cellular Mechanisms and Interventional Strategies

    ✓ Peer-reviewed alzhub usefulness score 37 out of 100. Journal of Neurochemistry 2026-05-01 Inflammation and the immune system

    The increase in senescent cells, including glial cells in the brain, is a general feature of normal aging and has been associated with age-related pathologies.

  15. Impact of Postlabeling Delay on Arterial Spin-Labeling MRI-Based Measures of Cerebral Blood Flow in a Simultaneous PET/MRI Study of Aging

    ✓ Peer-reviewed alzhub usefulness score 49 out of 100. American Journal of Neuroradiology 2026-04-23 Brain scans and imaging

    O]water PET were strongest for 1800 msec single-PLD and generally decreased with longer PLDs, except the occipital lobe, where all PLDs showed poor agreement.

  16. Microglial Plasticity in Vascular Dementia: Mechanisms and Therapeutic Reprogramming

    ✓ Peer-reviewed alzhub usefulness score 39 out of 100. International Journal of Molecular Sciences 2026-04-22 Disease mechanisms

    Vascular dementia (VaD) is a leading cause of cognitive decline and arises from heterogeneous cerebrovascular pathologies, most commonly cerebral small vessel disease and chronic cerebral hypoperfusion.

  17. Association of Left Ventricular Function With Cerebral Small Vessel Disease and Cognition

    ✓ Peer-reviewed alzhub usefulness score 53 out of 100. Journal of the American Heart Association 2026-04-16 Vascular contributions

    A total of 261 patients (75.3±6.8 years) were recruited from a memory-clinic cohort.

  18. Ischemic Stroke Incidence and Severity and Poststroke Cognitive Decline and Incident Dementia

    ✓ Peer-reviewed alzhub usefulness score 60 out of 100. JAMA Network Open 2026-04-16 Vascular contributions

    A total of 42 342 participants from the pooled cohorts were included (mean [SD] age, 61.3 [9.8] years; 55.0% female).

  19. Associations of Accelerated Biological Aging With the Presence and Longitudinal Progression of Cerebral Small Vessel Disease

    ✓ Peer-reviewed alzhub usefulness score 51 out of 100. Neurology 2026-04-10 Vascular contributions

    = 0.028), but not with progression of BG-EPVS or WMHs at follow-up.

  20. Cerebral small vessel disease burden relates to cognitive decline via impaired amyloid clearance in the general population

    ✓ Peer-reviewed alzhub usefulness score 52 out of 100. Journal of Cerebral Blood Flow & Metabolism 2026-04-10 Vascular contributions

    Our aim is to examine the interplay between cerebral small vessel disease (CSVD) pathology, Alzheimer’s disease (AD) related amyloid-β (Aβ) clearance, and cognition in general population.

  21. Neuroinflammation in vascular cognitive impairment and dementia: Insights from clinical biomarkers and experimental models

    ✓ Peer-reviewed alzhub usefulness score 41 out of 100. Journal of Cerebral Blood Flow & Metabolism 2026-04-10 Inflammation and the immune system

    Vascular cognitive impairment and dementia (VCID) encompasses a heterogeneous group of disorders in which cerebrovascular pathology contributes to cognitive decline.

  22. Modelling synaptic dysfunction in childhood dementia using human iPSC-derived cortical networks

    ✓ Peer-reviewed alzhub usefulness score 44 out of 100. Nature Communications 2026-04-07 Disease mechanisms

    Alterations in synaptic homeostasis are linked to cognitive and behavioural impairments in brain disorders.

  23. Microglial reactivity predicts hippocampal, but not global, atrophy in cerebral small vessel disease

    ✓ Peer-reviewed alzhub usefulness score 38 out of 100. Alzheimer s & Dementia 2026-04-01 Vascular contributions

    Our data suggests that microglial reactivity may play a role in hippocampal atrophy; potentially contributing to the increasingly recognized interaction between vascular and neurodegenerative pathology.

  24. Characterizing spatiotemporal white matter hyperintensity pathophysiology in vivo to disentangle vascular and neurodegenerative contributions

    ✓ Peer-reviewed alzhub usefulness score 58 out of 100. Nature Communications 2026-03-31 Vascular contributions

    White matter hyperintensities (WMHs) are neuroimaging markers widely interpreted as caused by cerebral small vessel disease, yet emerging evidence suggests that a subset may have a neurodegenerative etiology.

  25. Independent and interactive contributions of white matter hyperintensities and Alzheimer’s disease imaging and plasma biomarkers to cognitive decline in older adults without dementia

    ✓ Peer-reviewed alzhub usefulness score 41 out of 100. Alzheimer s Research & Therapy 2026-03-30 Vascular contributions

    Individual biomarkers significantly predict decline across multiple cognitive domains.

  26. LDL oxidation and cerebrovascular aging: mechanisms of endothelial dysfunction, inflammation, and vascular cognitive impairment and dementia

    ✓ Peer-reviewed alzhub usefulness score 43 out of 100. Redox Biology 2026-03-10 Inflammation and the immune system

    Vascular cognitive impairment and dementia (VCID) is increasingly recognized as one of the leading causes of cognitive decline in aging populations.

  27. Retinal microvascular dysfunction in mild cognitive impairment: Associations with cerebral small vessel disease, plasma biomarkers, and cognitive decline

    ✓ Peer-reviewed alzhub usefulness score 43 out of 100. Alzheimer s & Dementia 2026-02-01 Vascular contributions

    MCI exhibited greater retinal tortuosity (p < 0.05) and sparser vasculature (p < 0.001), correlating with higher PSMD, WMH volumes, and adverse plasma biomarkers (all p < 0.05).

  28. Feasibility and Tolerability of Performing Portable MRI for Neurological Disorders in an Outpatient Neurology Clinic: A Prospective Cohort

    ✓ Peer-reviewed alzhub usefulness score 43 out of 100. Annals of Clinical and Translational Neurology 2026-01-28 Brain scans and imaging

    These findings support the feasibility, tolerability, and high patient acceptability of pMRI.

  29. Neuroinflammation and blood–brain barrier dysfunction in cerebral small vessel disease: mechanisms, biomarkers, and therapeutic implications

    ✓ Peer-reviewed alzhub usefulness score 45 out of 100. European journal of medical research 2026-01-23 Inflammation and the immune system

    Cerebral small vessel disease (CSVD) is a chronic, progressive cerebrovascular disorder affecting small arteries, arterioles, venules, and capillaries, and is a leading contributor to stroke, vascular dementia, and cognitive impairment.

  30. White Matter Hyperintensities in Behavioral Variant Frontotemporal Dementia and Semantic Variant Primary Progressive Aphasia

    ✓ Peer-reviewed alzhub usefulness score 43 out of 100. Neurology Open Access 2026-01-23 Vascular contributions

    hexanucleotide repeat expansions (HRE) and WMH in bvFTD patients. bvFTD and svPPA are associated with elevated WMH burden independent of CVRF.

  31. Aquaporin-4 deficiency induced white matter injury via upregulated complement component 3 in cerebral small vessel disease

    ✓ Peer-reviewed alzhub usefulness score 35 out of 100. Journal of Neuroinflammation 2026-01-21 Vascular contributions

    We identified four SNPs (rs335929, rs335930, rs335931 and rs455671) were significantly associated with CSVD presence.

  32. They are often found in middle-aged individuals and are associated with a greater risk of stroke and vascular dementia.

  33. Older adults in more disadvantaged neighborhoods exhibit brain vascular dysfunction

    ✓ Peer-reviewed alzhub usefulness score 31 out of 100. Cerebral Circulation - Cognition and Behavior 2026-01-01 Risk factors

    Neighborhood disadvantage is a risk factor for dementia, but the mechanisms involved are not well understood.

  34. Silent yet impaired: Hidden memory processing deficits in asymptomatic individuals with moderate‐to‐severe white matter hyperintensities

    ✓ Peer-reviewed alzhub usefulness score 45 out of 100. Alzheimer s & Dementia 2026-01-01 Vascular contributions

    Individuals with msWMH showed systematic deficits in face-memory processing across encoding, maintenance, and retrieval, accompanied by reduced theta power and synchronization, altered alpha power, and disrupted theta-gamma coupling.

  35. The association of estimated glucose disposal rate with white matter hyperintensities: A large prospective cohort study

    ✓ Peer-reviewed alzhub usefulness score 43 out of 100. The Journal of Prevention of Alzheimer s Disease 2026-01-01 Vascular contributions

    Each 1-SD increase in eGDR was significantly associated with a reduction in WMH volume (β = -0.057; 95% CI: -0.062 to -0.051; p 0.05).

  36. Vascular dementia: World Stroke Organization fact sheet 2026

    ✓ Peer-reviewed alzhub usefulness score 51 out of 100. International Journal of Stroke 2026-01-01 Lewy body dementia

    There were 56.9 million people worldwide living with dementia in 2021, according to the Global Burden of Disease study, and this number is projected to exceed 137 million by 2050.

  37. Association of Plasma GFAP and NfL in Middle-Aged Adults With MRI Markers of Cerebral Small Vessel Disease Later in Life

    ✓ Peer-reviewed alzhub usefulness score 50 out of 100. Neurology 2025-12-29 Vascular contributions

    = 0.025) over 3 years. NfL was not significantly associated with any MRI cSVD marker.

  38. Correlation of White Matter Lesions, Cerebral Blood Flow, and Cognitive Decline in Patients With Alzheimer’s Disease and Vascular Dementia

    ✓ Peer-reviewed alzhub usefulness score 44 out of 100. Archives of Clinical Neuropsychology 2025-12-26 Cognitive tests and assessment

    Compared to controls, the AD/VaD patient group had a significantly higher WML volume (p < .001), reduced global CBF (p < .001), greater brain atrophy, and worse ADAS-Cog scores (p < .001).

  39. Oxidative Stress as a Central Mechanistic Bridge Between Alzheimer’s and Vascular Pathologies in Mixed Dementia: Emerging Evidence and Therapeutic Perspectives

    ✓ Peer-reviewed alzhub usefulness score 39 out of 100. Biomedicines 2025-12-26 Inflammation and the immune system

    Mixed dementia (MD), characterized by overlapping features of Alzheimer's disease (AD) and vascular dementia (VaD), represents the most prevalent form of late-life cognitive decline.

  40. Association Between Gas‐Free Cerebrovascular Reactivity ( CVR ) and Cognitive Function in Older Adults With a High Risk for Vascular Dementia

    ✓ Peer-reviewed alzhub usefulness score 48 out of 100. Journal of Magnetic Resonance Imaging 2025-12-23 Cognitive tests and assessment

    Whole-brain bm-CVR values were significantly associated with the diagnosis group of normal, MCI, and early dementia (β = -3.00%/mm Hg, 95% confidence interval (CI) [-5.42, -0.58]), and were lower in the impaired participants relative to participants with normal cognition (β = -2.18, CI [-3.91, -0.45]).

  41. Retinal microvascular alterations reflect cerebral small vessel disease burden in frontotemporal dementia: a multimodal OCTA–MRI Study

    ✓ Peer-reviewed alzhub usefulness score 45 out of 100. Alzheimer s Research & Therapy 2025-12-23 Getting a diagnosis

    FTD patients demonstrated significantly reduced retinal and choriocapillaris perfusion compared to CU (all p < 0.001).

  42. Shared Neuroinflammatory Mechanisms Across Dementia Types: An Integrative Review

    ✓ Peer-reviewed alzhub usefulness score 36 out of 100. International Journal of Molecular Sciences 2025-12-23 Inflammation and the immune system

    Dementia is a neurodegenerative condition marked by progressive cognitive decline, which affects people worldwide.

  43. Cerebral small vessel disease unveils a vascular pathway to motoric cognitive risk in aging

    ✓ Peer-reviewed alzhub usefulness score 55 out of 100. Journal of Alzheimer s Disease 2025-12-22 Vascular contributions

    In this multi-cohort study of older adults without cognitive impairment, we show that WMH and lacunes independently predict increased risk of MCR, after adjusting for key confounders.

  44. The impact of moxibustion on brain function in vascular dementia: a neuroimaging study involving amplitude of low-frequency fluctuations and functional connectivity

    ✓ Peer-reviewed alzhub usefulness score 32 out of 100. Frontiers in Neurology 2025-12-18 Cognitive tests and assessment

    Object On the basis of determining the clinical effect of moxibustion on vascular dementia (VD), this study explored the central mechanism of moxibustion on VD through fMRI.

  45. Transcranial direct current stimulation (tDCS) is a promising non-invasive intervention for mild cognitive impairment (MCI).

  46. Disentangling the relationship between glucose, insulin and brain health: A UK Biobank study

    ✓ Peer-reviewed alzhub usefulness score 42 out of 100. Diabetes Obesity and Metabolism 2025-12-12 Long-term cohort studies

    In UKB, higher 2-h post-load glucose was associated with a 69% increased Alzheimer's dementia risk (odds ratio 1.69 [95% confidence interval 1.38-2.07]), though this did not replicate in an independent GWAS.

  47. Deep neural networks and genome-wide associations reveal the polygenic architecture of local brain aging

    ✓ Peer-reviewed alzhub usefulness score 37 out of 100. GeroScience 2025-12-11 Risk factors

    -weighted magnetic resonance images of 41,708 cognitively normal adults in the UK Biobank.

  48. Patient inclusion started in January 2023, and study enrollment of patients is expected to finish in the second quarter of 2027, whereas the main results are expected to be published in the first quarter of 2028.

  49. Air under the skin, shadows in the mind: an enigmatic case report on hyperactive delirium or Sundowning triggered by subcutaneous emphysema postpneumothorax

    ✓ Peer-reviewed alzhub usefulness score 31 out of 100. Minerva Psychiatry 2025-12-01 Clinical safety

    Sundowning Syndrome (SS) is a clinically observed phenomenon, primarily associated with Alzheimer’s disease (AD), characterized by the exacerbation of neuropsychiatric symptoms during the late afternoon or evening, or in conditions of reduced ambient illumination.

  50. Association of hearing loss to brain structure and cognition in the Framingham Heart Study

    ✓ Peer-reviewed alzhub usefulness score 48 out of 100. Alzheimer s & Dementia 2025-12-01 Long-term cohort studies

    Midlife hearing loss was associated with smaller brain volumes, accelerated decline in executive function, accelerated accrual of white matter abnormalities, and a near doubling of dementia risk, suggesting a potential causal or biomarker role for midlife hearing loss in the prevention of late‐life dementia.

From across this tag

8 of the 902 studies in this tag, picked by a fixed rule (a hash of each study's address), not by score or date; each page of this list shows a different 8. The same 8 appear here every time.

All topic tags with their study counts